9 Must-Buy Penny Stocks to Invest In Now
A potential breakthrough in the US/Israel-Iran conflict lit fire under Wall Street on April 17.
Iovance Biotherapeutics Inc. (IOVA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Hurley Capital Charles Goldblum | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.84 | 30,000 | $55,200.00 | 30,000 | 2025-06-05 | Filing | |
| $1.74 | 5,600 | $9,743.44 | 206,852 | 2025-05-23 | Filing | |
| $1.69 | 25,000 | $42,250.00 | 374,646 | 2025-05-14 | Filing | |
| $9.15 | 250,000 | $2,287,500.00 | 320,150 | 2024-02-20 | Filing | |
| $9.15 | 32,000 | $292,800.00 | 54,000 | 2024-02-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.06 | 50,000 | $503,000.00 | 7,500 | 2024-11-12 | Filing | |
| $8.71 | 20,500 | $178,612.40 | 100,000 | 2016-08-25 | Filing | |
| $9.10 | 33,500 | $304,799.75 | 120,500 | 2016-08-24 | Filing | |
| $9.11 | 54,000 | $491,740.20 | 100,000 | 2016-08-22 | Filing | |
| $7.13 | 16,500 | $117,645.00 | 154,000 | 2015-09-08 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 16,617,737 | $58,328,257 | 0% | |
| 2. | 11,700,844 | $41,069,962 | 0% | |
| 3. | 3,664,278 | $12,861,616 | 0% | |
| 4. | 2,645,702 | $9,281,902 | 0% | |
| 5. | 2,184,298 | $7,666,886 | 0% |
News See All
Chardan Maintains a Buy on Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the best stocks under $5 with huge upside potential. Chardan reiterated a Buy rating on Iovance Biotherapeutics, Inc.
10 Stocks Under $5 with Huge Upside Potential
He cited the breadth of the market, stating that it's not just the Mag 7 or tech, but also the S&P, the Dow, the Nasdaq, and even the Russell that is moving higher.
Analyst Sentiment Remains Strong on Iovance Biotherapeutics (IOVA) Amid U.S. Rollout of Melanoma Drug, Amtagvi
Analyst sentiment toward Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) remains constructive.
10 Most Active Penny Stocks to Buy
The 2026 Iran conflict has resulted in a spike in volatility across markets, with the conflict expected to persist amid escalating geopolitical tensions. The broader investor sentiment is showing risk...
Iovance Biotherapeutics (IOVA) Announces Positive Early Data for Lifileucel TIL Therapy in Advanced Sarcomas
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds.
12 Best Get Rich Quick Stocks to Buy According to Hedge Funds
On March 9, Main Management CEO and Portfolio Manager Kim Arthur joined CNBC’s ‘Halftime Report’ to talk about what he’s seeing in his sector rotation fund, and whether the volatility is exacerbating...
Iovance (IOVA) Soars 33%, Hits All-Time High
The coverage came ahead of the biopharmaceutical firm’s participation in Barclays’ 28th Annual Global Healthcare Conference on Wednesday, March 11, where investors will watch out for cues and company...
10 Stocks Investors Are Watching Closely This Week
In the fourth quarter alone, Samsara Inc. (NYSE:IOT) swung to a net income of $22 million, reversing a net loss of $11.2 million in the same quarter a year earlier.
Iovance (IOVA) Hits 52-Week High as Analyst Doubles Price Target
On Wednesday, March 11, investors will be closely watching out for business updates from Iovance Biotherapeutics Inc.
Hedge Fund Resource Center